title: [Haemostatic disorders in children].
abstract: Haemorrhagic and thrombotic events occur in both children and adults. The underlying causes are congenital or acquired disorders. In contrast to haemorrhagic disorders, inherited thrombotic disorders nearly exclusively in association with additional external risk factors lead to thrombotic events predominantly during the newborn period and adolescence. It is necessary to be aware of age-specific properties of coagulation in order to correctly interpret clinical and laboratory findings and to provide optimal care for children with haemorrhagic and thrombotic complications.
authors.affiliation: Priv.-Doz. Dr. med. Karin Kurnik, Kinderklinik im Dr. von Haunerschen Kinderspital Klinikum der Universität München, Lindwurmstr. 4, 80337 München, Karin.Kurnik@med.uni-muenchen.de.
authors.forename: Karin
authors.initials: K
authors.lastname: Kurnik
authors.forename: Christoph
authors.initials: C
authors.lastname: Bidlingmaier
authors.forename: Sebastian
authors.initials: S
authors.lastname: Hütker
authors.forename: Martin
authors.initials: M
authors.lastname: Olivieri
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001780:Blood Coagulation Tests / Q000379:methods*; D002648:Child; D002675:Child, Preschool; D019317:Evidence-Based Medicine; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D020141:Hemostatic Disorders / Q000175:diagnosis* / Q000517:prevention & control*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D010808:Physical Examination; D063189:Symptom Assessment / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents
keywords: Haemostatic disorders; haemorrhagic disorders in children; therapy; thrombotic disorders in children